Table 1 Study patients and control subjects

From: Coupling factor 6 enhances the spontaneous microaggregation of platelets by decreasing cytosolic cAMP irrespective of antiplatelet therapy

 

Stroke

  
 

Atherothrombotic

Lacunar

Cardioembolic

Hemorrhagic

Non-stroke

Control subjects

Number

173

71

95

85

226

20

Age (years)

73±0.8

70±1.6

76±1.2

71±1.3

70±0.9

67±3.1

Gender (male)

115 (66%)

48 (68%)

52 (55%)

45 (53%)

119 (53%)

12 (60%)

Antiplatelet agents

 Aspirin

27 (16%)

8 (11%)

22 (23%)

10 (12%)

32 (14%)

3 (15%)

 Thienopyridine

20 (12%)

5 (7%)

4 (4%)

2 (2%)

45 (20%)

4 (20%)

 Cilostazol

14 (8%)

4 (6%)

1 (1%)

4 (5%)

32 (14%)

2 (10%)

 None

124 (72%)

57 (80%)

69 (73%)

72 (85%)

154 (68%)

12 (60%)

Risk factors

 Hypertension

138 (80%)**

60 (85%)**

74 (78%)**

76 (89%)**

147 (65%)

9 (45%)

 Dyslipidemia

109 (63%)**

41 (58%)**

48 (51%)*

35 (41%)

89 (39%)

4 (20%)

 Diabetes mellitu

66 (38%)*

27 (38%)

20 (21%)

16 (19%)

63 (28%)

3 (15%)

 Smoking

73 (42%)**

28 (39%)*

16 (16%)

26 (31%)

62 (27%)

2 (10%)

  1. *P<0.05, **P<0.01 versus control subjects.
Back to article page